Morgan Labbree, Author at Precision Medicine Group

White Paper: Unleashing the Power of Precision Medicine: Radioligand Therapy

Morgan Labbree2023-11-03T16:36:34-04:00Cell & Gene Therapy, News, Thought Leadership|

This article was originally published on This Month in Transformative Medicine on October 17, 2023

The current standard of cancer care has saved many lives, but these methods often come with incredibly difficult side effects. Advancements in technology have brought new options to cancer care that hope to provide meaningful outcomes while minimizing the impact to the patient’s quality of life.

In this white paper Anshul Mangal, President of Project Farma (PF) & Precision ADVANCE, and Sumit Verma, Co-founder and Partner at Orchestra Life Sciences, discuss the power and potential of radioligand therapies and its impact on the treatment of a number of cancers.

(more…)

On Demand: State of the Union for Advanced Therapies

Morgan Labbree2023-11-14T10:42:38-05:00Cell & Gene Therapy, Events|

Sponsored by Precision ADVANCE, this Endpoints webinar convened industry leaders to discuss the current state of the industry, and the future of advanced therapies including innovations in research and development, going from treating rare diseases to prevalent conditions, continued investment, and next-generation technologies. The panelists also discussed manufacturing and talent bottlenecks, and innovative reimbursement payment models. This discussion was moderated by Anshul Mangal: President (Precision ADVANCE & Project Farma), and included insights from Dan Kirby: Chief Commercial Officer (Orca Bio), Deborah Phippard: CSO (Precision for Medicine), Devyn Smith: CEO (Arbor Bio), Helen Sabzevari: President & CEO (Precigen) and Chad Salisbury: SVP (Project Farma).

(more…)

Conference: Precision Attends HLTH, 2023

Morgan Labbree2023-10-04T11:13:29-04:00Cell & Gene Therapy, Events, Thought Leadership|

Precision will be at HLTH 2023, October 8 – 11, in Las Vegas, NV. Connect with our team of experts as they lead meaningful discussions and attend networking events focused on innovation and transformation for better patient health and treatment outcomes.

Connect with one our experts!

Schedule a meeting with one our our experts by emailing precisionadvance@precisionmedicinegrp.com
Join Precision’s Ashwin Athri: EVP, Strategy, Innovation, and Partnerships (Precision Value & Health) for an insightful panel session on Sunday, October 8th titled, “Digital Deliberations: The Ins and Outs of Implementing a Digital Strategy”

(more…)

White Paper: Scaling Hope: The Growth of the Allogeneic Cell Therapy Sector

Morgan Labbree2023-09-22T15:39:39-04:00Cell & Gene Therapy, News, Thought Leadership|

In the rapidly evolving landscape of advanced therapies, allogeneic cell therapies have emerged as a promising avenue for addressing various disorders, including hematological malignancies, neurological conditions, and autoimmune or inflammatory diseases. With a number of clinical trials underway to evaluate their efficacy, allogeneic cell therapies hold significant potential in reshaping the way we approach treating numerous diseases.

In this white paper, Anshul Mangal, President of Project Farma & Precision ADVANCE and John Khoury, Executive Vice President of Project Farma (PF), discuss the growth of the allogeneic cell therapy sector and its impact on patient access.

(more…)

Conference: Association for Value-Based Cancer Care 2023 Educational Summit & Program

Morgan Labbree2023-10-16T09:57:04-04:00Cell & Gene Therapy, Events, Thought Leadership|

Precision will be at this year’s Association for Value-Based Cancer Care 2023 Educational Summit & Program, October 18 – 20, NYC, NY. This exclusive invitational forum provides invaluable time with more than 200 diverse experts representing every stakeholder of the cancer care ecosystem.

Don’t miss an opportunity to celebrate groundbreaking science and network with industry leaders!

Schedule a meeting with one of our experts

Speaking Engagements
Detailed descriptions for each speaking engagement are included below.

Precision’s, Phil Cyr: SVP (Precision Value & Health) will facilitate a panel session on Wednesday, October 18th titled, “Cell and Gene Therapy and the Future Impact on Cancer Care”
Precision’s, Andy Kinley: VP, Innovation and Clinical Science (Precision for Medicine) will facilitate a panel session on Thursday, October 19th titled, “Evolution of Clinical Trials”

You can register for the Association for Value-Based Cancer Care 2023 Educational Summit & Program below:

REGISTER HERE

(more…)

Webinar: Rise of mRNA manufacturing

Morgan Labbree2023-09-13T19:38:47-04:00Cell & Gene Therapy, Events|

Sponsored by Project Farma, a Precision for Medicine Company, this panel will feature insights from industry leaders on the current state of the market for mRNA-based medicines, techniques to optimize manufacturing and technical operations, and strategies for CQV, quality, automation & engineering for mRNA facilities.

This discussion will be moderated by Anshul Mangal: President (Project Farma & Precision ADVANCE), and include insights from Aaron Allen: Director, Global Quality, External Engagement (Moderna), Andrew Geall: Co-founder and Chief Development Officer (Replicate Bioscience), Jane True: Global VP, mRNA Commercial Strategy Innovation & Pandemic Security Lead (Pfizer), Venkata Indurthi: CSO (Aldevron), and Chad Salisbury: SVP (Project Farma).

(more…)

Conference: Meeting on the Mesa, 2023

Morgan Labbree2023-09-21T11:02:57-04:00Cell & Gene Therapy, Events, Thought Leadership|

Precision will be at this year’s Meeting on the Mesa, October 10-12, 2023, in Carlsbad, CA. Connect with our team of experts as they lead meaningful presentations and discussions throughout this event providing insights into the clinical development, manufacturing, and commercialization for cell and gene therapies.

Connect with our Advanced Therapy experts

Visit us through any of the numerous networking opportunities at Meeting on the Mesa 23′
Be sure to attend the ADVANCE sponsored Plenary Session on October 10, 2023, 9:30 – 10:30 AM PT |Location: Park Hyatt Aviara (Aseptic Technologies Ballroom)
Join us for the ADVANCE sponsored Cocktail Reception on October 11, 2023, 6:00-7:00 PM PT

You can register for Meeting on the Mesa below:

REGISTER HERE

(more…)

Event: Endpoints 11, 2023

Morgan Labbree2023-08-28T15:25:37-04:00Cell & Gene Therapy, Events, Thought Leadership|

Precision is honored to be a sponsor of this year’s Endpoints 11 taking place on September 20, 2023, in Boston, MA. Join a select group of industry leaders for this year’s awards gala as we gather at the State Room in Downtown Boston for an evening of dinner, drinks and networking to meet the future of biotech.

Connect with our Advanced Therapy experts!

Date: Wednesday, September 20, 2023
Time: 5:30pm – 10:30 pm ET
Location: State Room, Boston, MA

CLICK HERE to reserve your spot.

(more…)

Conference: 4th Annual Gene Therapy Immunogenicity Summit

Morgan Labbree2023-08-24T13:33:14-04:00Cell & Gene Therapy, Events, Thought Leadership|

Precision will be at this year’s 4th Annual Gene Therapy Immunogenicity Summit, September 5 – 7, 2023, in Boston, MA. Connect with our team of experts as they lead meaningful presentations and discussions throughout this event providing insights into the development for cell and gene therapies.

Connect with our Advanced Therapy experts!

Schedule a meeting with one our our experts
Stop by Precision’s booth
Be sure to attend Precision’s own, Travis Harrison’s presentation on September 6th, 2023, at 9:30 AM EDT

You can register for the 4th Annual Gene Therapy Immunogenicity Summit below:

REGISTER HERE

(more…)

White Paper: Cell and Gene Therapies: How High Can Prices Go?

Morgan Labbree2023-08-11T13:10:02-04:00Cell & Gene Therapy, News, Thought Leadership|

The concept of optimizing CGT value propositions begs the question of what is reasonable when it comes to breakthrough science and unprecedented therapeutic solutions. Can a $5 million price tag be justified? What about $10 million?

This white paper is based on a webinar convened by PRECISIONadvisors, focusing on cell and gene therapy (CGT) pricing. The webinar featured two in-house experts from the PRECISIONadvisors Global Pricing & Market Access practice: Richard Macaulay, Senior Vice President and David Carr, Senior Director.

(more…)

About Morgan Labbree